MedPath

Impact of Sourdough Bread Consumption on Long-term Energy Intake: A Pilot Study of Feasibility

Not Applicable
Recruiting
Conditions
Energy Intake
Overweight and Obesity
Body Weight Changes
Appetite Regulation
Eating Behavior
Registration Number
NCT05590611
Lead Sponsor
KU Leuven
Brief Summary

The present study is a pilot study examining whether long-term sourdough bread consumption reduces energy intake and blood lipids levels over a period of 4 weeks in free-living normalweight and overweight participants.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Female and male participants
  • Age range 18 - 50
  • BMI range >20 kg/m2 at screening visit
  • Regular eating pattern (3 meals per day on at least 5 days per week)
  • Habitual brown bread consumption of at least 1 slice per day (assessed by The European Prospective Investigation into Cancer (EPIC) Norfolk FFQ)
  • Stable body weight for the last 6 months
Exclusion Criteria
  • Currently smoking or willingness to smoke during the study period
  • Pregnancy, lactation or wish to become pregnant during the study period
  • Previous or current gastrointestinal or endocrine disorders
  • Previous or current substance/alcohol dependence or abuse (> 2 units per day/14 units per week)
  • Coeliac disease or gluten sensitivity
  • Allergy/intolerance to milk, egg, nuts, soy or sesame
  • Habitual sourdough bread consumption of at least 1 slice per day (assessed by The European Prospective Investigation into Cancer (EPIC) Norfolk FFQ)
  • Excessive concern about eating habits or body weight as evidenced from scores < 18 on the restraint and disinhibition subscales of the Three-Factor Eating Questionnaire (Stunkard & Messick, 1985)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Energy intake (kilocalories)4 weeks

Assessed via 4-day food diaries using a mobile app

Secondary Outcome Measures
NameTimeMethod
Body weight4 weeks
Blood lipid levels4 weeks

Plasma total cholesterol, triglycerides, LDL and HDL cholesterol, colourimetrically

Trial Locations

Locations (1)

KU Leuven

🇧🇪

Leuven, Vlaams Brabant, Belgium

KU Leuven
🇧🇪Leuven, Vlaams Brabant, Belgium
Georgia Chatonidi
Contact
+32 16 19 43 24
georgia.chatonidi@kuleuven.be
Kristin Verbeke
Contact
+32 16 33 01 50
kristin.verbeke@kuleuven.be

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.